If you hold U.S.-listed Chinese stocks like Alibaba Group Holding Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NASDAQ">BABA</a>), JD.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) or PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), you may soon face serious liquidity risks, as delisting threats tied to geopolitical and regulatory frictions between Washington and Beijing <a href="https://www.benzinga.com/topic/tariffs">mount with fresh urgency.</a>



In a note shared Thursday, Goldman Sachs analyst Kinger Lau, CFA, said delisting fears for Chinese American Depositary Receipts (ADRs) are rising again, driven by escalating trade tensions and new policy guidance from U.S. officials, including President Donald Trump&#8216;s America First Investment Policy and Treasury Secretary Scott Bessent's statement that "everything is on the table" in the response to China's retaliatory tariffs.



According to Goldman Sachs&#8217; ADR Delisting Barometer, there is currently a 66% probability of delisting risk embedded in Chinese ADRs. A full pricing in of delisting risk could lead to a 9% drop in ADR valuations from current levels. 



&#8220;U.S. listings by Chinese companies is widely regarded as an embodiment of financial market relations and a leverage for the potential negotiation between the two nations,&#8221; Lau wrote.



<h1 class="wp-block-heading">How High Are The Stakes?</h1>



&#8220;We estimate that U.S. institutional investors currently own around U.S.$830 billion of Chinese stocks across A shares, H shares and ADRs,&#8221; Goldman Sachs stated. Of this, approximately $250 billion is tied up in ADRs specifically.



At the same time, Chinese investors could be forced to offload up to $1.7 trillion in U.S. financial assets, including approximately $370 billion in equities and $1.3 trillion in bonds.



This extreme scenario — which alludes to a full investment ban — would represent the largest forced unwind of cross-border holdings in modern financial history.



<h1 class="wp-block-heading">Who Gets Hit The Hardest?</h1>



According to Goldman's analysis, 5% of Alibaba's and 3% of PDD's market cap is owned by U.S. institutions that currently don't own other Hong Kong-listed stocks such as Tencent or Meituan. That means they may not have operational flexibility to pivot to Hong Kong in the event of delisting.



Roughly 20% of U.S. institutional holdings in top ADRs — equivalent to 7% of the total market cap — may face similar constraints, meaning they may be forced sellers.



For Alibaba, there are 1,275 institutional holders globally, and institutional investors collectively own 50% of the company&#8217;s outstanding shares. Out of that, 26% of Alibaba's total shares are held by U.S.-based institutions, with 176 U.S. institutional investors holding positions larger than 0.005% of the company's total shares.



For PDD, the figures are more concentrated: it has 1,006 institutional holders, with institutions holding 31% of the stock overall. 16% of the total shares are held by U.S. institutional investors, and there are 107 U.S.-based institutional holders with significant stakes (above 0.005% ownership).



In short, the data suggests Alibaba has both broader and deeper institutional engagement, especially from U.S. investors, compared to PDD. This means that, in the event of a U.S. delisting, Alibaba could see a greater volume of forced selling from U.S. institutional investors due to the larger size and scale of U.S. holdings.



<h1 class="wp-block-heading">Are ETFs And Derivatives at Risk?</h1>



Yes. Passive funds and ETF products are particularly exposed. The KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>) has 33% of its assets in ADRs, half of which do not have Hong Kong listings, making it vulnerable in a forced delisting scenario.



Other funds, like the iShares MSCI China ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCHI#NYSE">MCHI</a>), have already shifted weightings from ADRs to Hong Kong shares, thanks to changes in primary ticker designations by index providers like MSCI.



In derivatives markets, any forced delisting of ADRs could trigger early termination events under ISDA contracts, potentially unwinding outstanding options and swaps linked to these securities.



<h1 class="wp-block-heading">What Happens In A Delisting Event?</h1>



If a delisting takes place, investors may have a few paths forward depending on how the company is structured. For firms with dual listings, investors can convert their ADRs into Hong Kong-listed shares through the depositary bank. 



This process typically takes about two business days and may involve fees and applicable taxes. In some cases, investors might be able to sell their shares on over-the-counter (OTC) markets, although this route is blocked for companies delisted under the Holding Foreign Companies Accountable Act (HFCAA) or sanctioned by the Office of Foreign Assets Control (OFAC). 



If no action is taken by the investor, the ADR program will eventually be terminated and the depositary will sell the underlying shares, distributing the net proceeds in cash after deducting fees.



Read Now: 



<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44862662/trump-pressures-fed-as-ecb-delivers-7th-straight-rate-cut">Trump Pressures Fed As ECB Delivers 7th Straight Rate Cut</a></li>
</ul>



Photo: Shutterstock

Asia

Equities

Government

Large Cap

Macro Economic Events

Regulations

Specialty ETFs

Global

Econ #s

Economics

Tech

ETFs

BABA

KWEB

MCHI

US-Listed Chinese Stocks Face $250 Billion Forced Selling Risk As Delisting Fears Emerge: What Investors Need To Know

Crypto analyst Benjamin Cowen anticipates that Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) will maintain its dominance over altcoins until there are alterations in the US monetary policy.



What Happened: In a video post on Wednesday, Cowen communicated his insights to his 892,000 YouTube subscribers. He anticipates that the total market cap of altcoins, excluding Bitcoin and Ethereum, will persist in its decline against Bitcoin.



Cowen&#8217;s prediction is that Bitcoin will continue to outperform altcoins until the US Federal Reserve relaxes its monetary policy. &#8220;My base case right now for Bitcoin dominance is that it will likely go higher until quantitative tightening is over,&#8221; Cowen expressed in the <a href="https://www.youtube.com/watch?v=QMU14i4PIYk">post</a>.



The term Bitcoin dominance refers to the proportion of Bitcoin&#8217;s total market capitalization in comparison to all other crypto assets. A rise in Bitcoin dominance signifies that Bitcoin is either ascending faster than other crypto assets or its descent is less severe.



Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44884222/bitcoin-solana-and-pepe-show-bullish-reversal-signs-amid-market-recovery">Bitcoin, Solana and Pepe Show Bullish Reversal Signs Amid Market Recovery</a>



Regarding the timeline for the Federal Reserve to relax its monetary policy, Cowen said, &#8220;Now, I don&#8217;t know how long it&#8217;s&nbsp;going to take them to&nbsp;end quantitative tightening, it&#8217;s&nbsp;possible they end it this&nbsp;summer.&#8221;



At the time of the report, Bitcoin was trading at $84,270.



Why It Matters: The dominance of Bitcoin over altcoins has significant implications for investors and the broader cryptocurrency market. If Bitcoin continues to outperform altcoins, it could lead to a consolidation of investment in Bitcoin, potentially driving its price even higher. 



Conversely, a shift in the US monetary policy that leads to an easing of the Federal Reserve&#8217;s current stance could disrupt this trend, leading to a more even distribution of investment across different cryptocurrencies. 



This prediction by Cowen provides valuable insight for investors navigating the volatile cryptocurrency market.



Read Next



<a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44065728/crypto-analyst-predicts-195-bitcoin-rally-says-bull-market-not-over-yet" target="_blank" rel="noreferrer noopener">Crypto Analyst Predicts 195% Bitcoin Rally, Says Bull Market Not Over Yet</a>

Cryptocurrency

News

$BTC

This Crypto Analyst Forecasts Bitcoin's Superiority Over Altcoins Until This Happens

President&nbsp;Donald Trump&nbsp;has excluded a range of technology products, including certain consumer electronics made in China, from the reciprocal tariffs. The list of exemptions, released by U.S. Customs and Border Protection, effectively <a target="_blank" href="https://www.benzinga.com/25/04/44784092/apple-smci-nvidia-and-amd-stocks-climb-in-monday-pre-market-whats-going-on" rel="noreferrer noopener">reduces the scope of the imposed levies</a>.



The exclusions apply to smartphones, laptops, hard drives, and computer processors and memory chips, shielding them from Trump&#8217;s proposed 125% tariff on Chinese goods and the baseline 10% global tariff on most other countries.



Pedestrians in at least three California cities were met with bizarre AI-generated voice clips mimicking Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and SpaceX CEO Elon Musk and Meta Platforms Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) Mark Zuckerberg after crosswalk buttons were <a href="https://www.benzinga.com/25/04/44784312/hacked-crosswalk-buttons-in-california-cities-play-ai-generated-elon-musk-zuckerberg-voice-clips-mocking-democracy-and-begging-for-friends" target="_blank" rel="noreferrer noopener">reportedly hacked over the weekend.</a>



Automotive



Rivian Automotive Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) founder and CEO RJ Scaringe has said the company boasts a "U.S.-centric" supply chain amid&nbsp;Donald Trump&#8216;s 25% <a target="_blank" href="https://www.benzinga.com/tech/25/04/44836493/rivians-us-centric-supply-chain-could-offer-edge-amid-trumps-auto-tariffs-says-ceo-rj-scaringe" rel="noreferrer noopener">tariffs on the auto industry</a>.



Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has released a cheaper, long-range version of the Model Y facelift. The new version replaces the limited-run launch edition, which is no longer <a target="_blank" href="https://www.benzinga.com/25/04/44809616/heres-how-the-new-2025-tesla-model-y-long-range-differs-from-the-limited-run-launch-edition" rel="noreferrer noopener">available for sale by the company</a>.



A&nbsp;Tesla Model Y was spotted testing in India&#8217;s Mumbai, adding to the anticipation of <a target="_blank" href="https://www.benzinga.com/tech/25/04/44833951/elon-musk-led-teslas-model-y-spotted-testing-in-mumbai-ahead-of-india-debut" rel="noreferrer noopener">the company&#8217;s debut in India</a>.



Social Media/Entertainment



Netflix Inc.&nbsp;has begun testing an artificial intelligence–powered search engine that enables subscribers to find movies and TV shows based on their emotions, <a href="https://www.benzinga.com/25/04/44778760/netflix-debuts-openai-backed-search-engine-that-lets-you-discover-movies-and-tv-shows-based-on-emotions-not-just-titles" target="_blank" rel="noreferrer noopener">preferences, or specific situations</a>.



TikTok‘s U.S. public policy chief,&nbsp;Michael Beckerman, is leaving his Washington-based role to transition <a href="https://www.benzinga.com/general/social-media/25/04/44856624/tiktoks-us-policy-chief-steps-down-as-bidding-war-heats-up-after-trump-extends-deadline-report">to a global advisory position</a>.



Technology



Nvidia Corp.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) and&nbsp;Alphabet Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) have reportedly decided to invest in the artificial intelligence startup co-founded by former&nbsp;<a target="_blank" href="https://www.benzinga.com/25/04/44778730/nvidia-and-alphabet-to-back-openai-co-founder-ilya-sutskevers-new-ai-startup-safe-superintelligence-report" rel="noreferrer noopener">OpenAI&nbsp;</a><a target="_blank" href="https://www.benzinga.com/25/04/44778730/nvidia-and-alphabet-to-back-openai-co-founder-ilya-sutskevers-new-ai-startup-safe-superintelligence-report" rel="noreferrer noopener">chief scientist&nbsp;</a><a target="_blank" href="https://www.benzinga.com/25/04/44778730/nvidia-and-alphabet-to-back-openai-co-founder-ilya-sutskevers-new-ai-startup-safe-superintelligence-report" rel="noreferrer noopener">Ilya Sutskever</a>.



Alphabet Inc.&#8217;s&nbsp;Google&nbsp;rolled out its&nbsp;Veo 2&nbsp;model <a target="_blank" href="https://www.benzinga.com/tech/25/04/44832438/googles-veo-2-will-allow-you-to-create-high-resolution-videos-with-text-in-gemini-app-sundar-pichai-shows-off-cyberpunk-style-anime" rel="noreferrer noopener">to&nbsp;</a><a target="_blank" href="https://www.benzinga.com/tech/25/04/44832438/googles-veo-2-will-allow-you-to-create-high-resolution-videos-with-text-in-gemini-app-sundar-pichai-shows-off-cyberpunk-style-anime" rel="noreferrer noopener">Gemini Advanced</a><a target="_blank" href="https://www.benzinga.com/tech/25/04/44832438/googles-veo-2-will-allow-you-to-create-high-resolution-videos-with-text-in-gemini-app-sundar-pichai-shows-off-cyberpunk-style-anime" rel="noreferrer noopener">&nbsp;users</a>.



Alphabet Inc.&#8217;s&nbsp;Google&#8217;s DeepMind&nbsp;is diving into marine science with a new AI model designed to help <a target="_blank" href="https://www.benzinga.com/25/04/44833198/can-ai-talk-to-dolphins-googles-deepmind-creates-dolphingemma-to-explore-animal-language" rel="noreferrer noopener">researchers decode dolphin communication</a>.



Meta Platforms announced Friday it will appoint&nbsp;Dina Powell&nbsp;McCormick&nbsp;and&nbsp;Stripe&nbsp;CEO&nbsp;Patrick Collison&nbsp;to its board of directors, effective April 15. The move increased the <a target="_blank" href="https://www.benzinga.com/25/04/44782094/meta-board-shake-up-trump-era-veteran-dina-powell-and-stripe-ceo-join-as-zuckerberg-reshapes-companys-political-and-strategic-direction" rel="noreferrer noopener">board&#8217;s size to 15 members</a>.



Microsoft Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) announced a research preview of &#8220;Computer Use,&#8221; a new tool within&nbsp;Copilot Studio&nbsp;that enables AI agents to perform tasks on desktop and web <a href="https://www.benzinga.com/25/04/44831264/microsoft-debuts-computer-use-tool-for-copilot-studio-ceo-satya-nadella-says-anyone-can-build-agents-that-take-action-on-the-ui-across-desktop-and-web-apps" target="_blank" rel="noreferrer noopener">applications by interacting directly</a>.



Bill Gates&nbsp;says artificial intelligence will soon wipe out chronic shortages of skilled workers like doctors and teachers, eventually forcing societies to rethink the value of <a href="https://www.benzinga.com/tech/25/04/44857520/bill-gates-says-his-kids-and-grandkids-will-live-in-a-very-changed-world-as-ai-puts-an-end-to-shortage-of-teachers-and-doctors">time and the concept of ‘work hours</a>'.



Smartphones



Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) investors breathed a much-needed sigh of relief on Friday when the Trump administration announced a decision to exempt iPhones, iPads, and Macs from the latest wave of reciprocal tariffs. This might have saved the<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44788262/apples-margins-catch-a-break-but-road-ahead-still-looks-bumpy" target="_blank" rel="noreferrer noopener"> company from a near-term cost storm</a>.



Image: Shutterstock/Gorodenkoff

AAPL

GOOG

MSFT

NFLX

RIVN

TSLA

Consumer Tech News (Apr 14-Apr 18): Trump's 125% China Tariff Sidesteps Consumer Tech, Tesla Model Y Spotted in India & More

Benzinga examined the prospects for <a href="http://www.benzinga.com/trading-ideas" target="_blank" rel="noreferrer noopener">many investors' favorite stocks</a> over the last week — here's a look at some of our top stories.



U.S. markets faced heightened volatility this week as the Trump administration intensified trade restrictions, notably imposing new export controls on Nvidia's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) H20 AI chip to China. Nvidia projected a $5.5 billion revenue impact, leading to an 8.5% drop in its stock and a broader 3% decline in the semiconductor sector.



Federal Reserve Chair Jerome Powell cautioned that the tariffs could exacerbate inflation, prompting criticism from President Donald Trump. Amid these tensions, gold prices surged to a record $3,330 per ounce, reflecting increased investor anxiety.



In corporate earnings, UnitedHealth Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) unexpected downward revision of its full-year guidance led to a 22.4% plunge in its stock — the steepest single-day drop since 1998. Conversely, Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) reported strong performance, providing some optimism amid the market turbulence.



Benzinga provides daily reports on the stocks most popular with investors. Here are a few of this past week's most bullish and bearish posts that are worth another look.



The Bulls



<a href="https://www.benzinga.com/general/entertainment/25/04/44877995/netflix-crushes-q1-says-its-working-hard-to-improve-and-expand-its-offering">"Netflix crushes Q1, says it's ‘working hard to improve and expand' its offering"</a>, by Chris Katje, reports that Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) exceeded expectations with $10.54 billion in Q1 revenue, a 12.5% year-over-year increase, driven by higher subscription and ad revenue, while emphasizing plans to enhance its content lineup — including the June 27 return of Squid Game — and expand its ad tech platform globally.



<a href="https://www.benzinga.com/trading-ideas/movers/25/04/44824755/palantir-stock-is-on-fire-this-week-outpacing-broader-markets-whats-going-on">"Palantir stock is on fire this week, outpacing broader markets: What's going on?"</a>, by Adam Eckert, reports that Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares rose nearly 25% over five sessions after announcing a partnership with NATO Allied Command Operations to supply AI-enabled warfighting technology, a move Wedbush analyst Dan Ives called a "major win" that validates the company's platform.



<a href="https://www.benzinga.com/general/biotech/25/04/44878381/eli-lilly-rallies-over-14-notches-best-day-since-june-2000-on-oral-weight-loss-drug-results-analysts-react">"Eli Lilly rallies over 14%, notches best day since June 2000 on oral weight-loss drug results: Analysts react"</a>, by Piero Cingari, reports that Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) shares surged 14.36% — marking their best day since June 2000 — after its oral GLP-1 drug orforglipron achieved significant weight loss and blood sugar control in a Phase 3 trial, prompting analysts to dub it a potential "Ozempic in a pill."



For additional bullish calls of the past week, check out the following:



<a href="https://www.benzinga.com/trading-ideas/movers/25/04/44853443/hertz-stock-accelerates-into-the-close-shares-continue-to-move-higher-after-hours-heres-why">Hertz Stock Accelerates Into The Close, Shares Continue To Move Higher After Hours: Here's Why</a>



<a href="https://www.benzinga.com/25/04/44870886/why-nvidia-meta-and-3-more-are-this-strategists-top-buys-this-week-and-why">Nvidia, Meta And 3 More Stocks Are This Strategist's Top Buys: Here's Why</a>



<a href="https://www.benzinga.com/trading-ideas/movers/25/04/44817059/usa-rare-earth-stock-continues-to-surge-whats-going-on">USA Rare Earth Stock Continues To Surge: What's Going On?</a>



The Bears



<a href="https://www.benzinga.com/general/health-care/25/04/44860240/unitedhealth-slashes-2025-outlook-on-medicare-funding-reductions-stock-crashes">"UnitedHealth slashes 2025 outlook on Medicare funding reductions, stock crashes"</a>, by Vandana Singh, reports that UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares plunged over 22% after the company cut its 2025 adjusted EPS guidance to $26–$26.50, citing higher-than-expected care activity in its Medicare Advantage business and reduced reimbursement rates.



<a href="https://www.benzinga.com/25/04/44789084/starbucks-stock-brews-a-bitter-blend-of-boycotts-and-bearish-charts">"Starbucks Stock Brews A Bitter Blend Of Boycotts And Bearish Charts"</a>, by Surbhi Jain, reports that Starbucks Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) shares have declined nearly 13% over the past month as the company faces political backlash from a viral #BoycottStarbucks campaign and bearish technical indicators, with the stock trading below its 8-, 20-, 50-, and 200-day simple moving averages.



<a href="https://www.benzinga.com/news/earnings/25/04/44802241/applied-digital-q3-earnings-revenue-misses-estimates-despite-strong-cloud-services-growth-shares-slide">"Applied Digital Q3 earnings: Revenue misses estimates despite strong cloud services growth, shares slide"</a>, by Adam Eckert, reports that Applied Digital Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) posted third-quarter revenue of $52.9 million — falling short of analyst expectations of $63.42 million — while its Cloud Services division grew 220% year-over-year, and the company recorded an adjusted loss of 8 cents per share, beating estimates for an 11-cent loss.



For more bearish takes, be sure to see these posts:



<a href="https://www.benzinga.com/25/04/44841356/chip-stocks-are-facing-selling-pressure-wednesday-heres-why">Chip Stocks Are Facing Selling Pressure Wednesday: Here's Why</a>



<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44850301/target-under-pressure-from-discretionary-spend-slowdown-mounting-inventory-risk-goldman-sachs-downgrades-stock">Target Under Pressure From Discretionary Spend Slowdown, Mounting Inventory Risk, Goldman Sachs Downgrades Stock</a>



<a href="https://www.benzinga.com/25/04/44802015/us-electric-vehicle-sales-up-11-in-q1-as-tesla-declines-the-winners-and-losers">Tesla Loses Steam In Q1 While US EV Sales Climb: The Winners And Losers</a>



Keep up with all the latest breaking news and trading ideas by following <a href="https://twitter.com/Benzinga" target="_blank" rel="noreferrer noopener">Benzinga</a><a href="http://twitter.com/Benzinga" target="_blank" rel="noreferrer noopener"> on X</a>.



Image created using artificial intelligence via Midjourney.

Markets

APLD

NVDA

PLTR

SBUX

USAR

Benzinga Bulls And Bears: Netflix, UnitedHealth, Eli Lilly — And Market Volatility Continues

From the halls of Congress to the streets of New York, cannabis news bloomed in every direction this week. Slovenia introduced what may become Europe's most progressive medical cannabis law. U.S. lawmakers filed new federal reform legislation. Trulieve and Curaleaf took diverging paths in Florida. And Governor Ron DeSantis faces questions over whether public funds were funneled into anti-cannabis campaigns.



Elsewhere, Weedmaps dropped a custom sneaker collab, Swatch&#8217;s 4/20-friendly watch returned to the spotlight and a massive new cancer study delivered groundbreaking validation for medical cannabis. Avicanna posted record earnings, Minnesota crossed a regulatory milestone and Blue Violets made delivery history in New Jersey.



Here's everything you need to know.



<h3 class="wp-block-heading">Business And Financial Moves</h3>



Avicanna Reports Record Year



Avicanna Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AVCN#TSX">AVCN</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/AVCNF#OTCQX">AVCNF</a>) reported audited financial results for 2024, including $25.5 million in revenue—a 52% increase over 2023—and gross profits of $12.9 million, up 94%. Consolidated gross margins improved to 51%, while adjusted EBITDA losses narrowed by 68% to $1.4 million. The company also repaid $1.3 million in debt.



CEO Aras Azadian called 2024 "our most successful year to date," citing clinical innovation, international expansion, and commercial growth in Canada and abroad.



Key 2024 milestones include:



<ul>
<li>A real-world evidence study in Canada evaluating cannabis for conditions like pain, sleep, anxiety and epilepsy</li>



<li>A completed study at The Hospital for Sick Children assessing CBD topical creams for wound healing</li>



<li>Drug approval in Colombia for Trunerox, targeting rare epileptic disorders</li>



<li>First delivery of CBD/CBG topicals to a multinational pharmaceutical company</li>



<li>Two new U.S. patents for topical and oral cannabinoid delivery technologies</li>
</ul>



<a href="https://www.benzinga.com/news/earnings/25/04/44802163/why-cannabis-focused-biopharma-co-avicanna-traded-up-26-today">Read the full story here</a>.



Tilray Plans Reverse Stock Split



Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) will hold a special shareholder meeting on June 10 to vote on a proposed reverse stock split ranging from 1-for-10 to 1-for-20. CEO Irwin Simon said the move aims to maintain Nasdaq compliance, reduce costs by more than $1 million per year, and attract institutional investors. The company recently reported over $248 million in cash and trimmed debt by $76 million.



<a href="https://www.benzinga.com/markets/cannabis/25/04/44871447/why-cannabis-co-tilray-tlry-is-trading-down-today">Read more on Benzinga</a>



Safe Harbor and FundCanna Join Forces



SHF Holdings, d/b/a Safe Harbor Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>), announced a strategic partnership with FundCanna to provide cannabis operators with streamlined access to capital and compliant banking services. The agreement enables mutual referrals and onboarding of FundCanna-approved clients into Safe Harbor-managed accounts.



"This partnership delivers a practical, scalable solution that puts the financial needs of cannabis operators first," said Safe Harbor CEO Terry Mendez.



<h3 class="wp-block-heading">Politics, Policy And Regulation</h3>



Congress Reintroduces STATES 2.0 Act



A bipartisan group of U.S. lawmakers reintroduced the STATES 2.0 Act, which would shield legal cannabis activity from federal interference. The bill would also legalize interstate commerce, normalize IRS treatment of cannabis businesses and establish a framework for federal oversight and testing.



"The current federal approach to cannabis policy is not working," said Rep. Dave Joyce (R-OH), co-chair of the Congressional Cannabis Caucus. "The STATES 2.0 Act creates a more logical approach that protects states' rights while improving public safety."



The bill maintains FDA oversight for cannabis products, removes barriers to tax deductions under Section 280E, and instructs federal agencies to begin rulemaking within 180 days of passage. Supporters include Reps. Max Miller (R-OH), Dina Titus (D-NV) and a coalition of advocacy organizations including CPEAR, Americans for Prosperity, and the U.S. Cannabis Roundtable.



<a class="" href="https://www.marijuanamoment.net">Read more via Marijuana Moment</a>



Minnesota Finalizes Adult-Use Cannabis Rules



The Minnesota Office of Cannabis Management (OCM) announced that final adult-use rules were published in the State Register and are now in effect. With this step completed, OCM can begin issuing business licenses to qualifying applicants, including more than 600 social equity applicants already advanced through preapproval.



"We are continuing to prioritize social equity in every stage of licensing," said Jess Jackson, OCM's director of social equity. Licenses for capped categories such as cultivator and retailer will be awarded via lottery later this summer, while uncapped license types will be distributed on a rolling basis.



<a class="" href="https://cannabis.mn.gov">Details available on the OCM Rulemaking page</a>



Slovenia Unveils Progressive Medical Cannabis Law



Slovenia's Parliament introduced sweeping medical cannabis reforms that would legalize the cultivation, production and distribution of cannabis for medical and scientific use. The bill eliminates public tenders, allows open licensing for private companies and removes cannabis and THC from the country's prohibited drugs list—so long as products meet GACP, GMP and European Pharmacopeia standards.



Cannabis will be available via standard medical or veterinary prescriptions, and patient access is guaranteed through pharmacies, licensed distributors and healthcare providers.



The legislation follows a 2024 referendum in which 66.7% of voters supported cannabis cultivation and legalization for medical use. According to ICBC, the new framework would position Slovenia as having the most advanced medical cannabis law in Europe.



<a class="" href="https://internationalcbc.com/slovenian-parliament-introduces-europes-most-progressive-medical-cannabis-law">Full article via ICBC</a>



DeSantis Faces Scrutiny Over Anti-Cannabis Funding



A Miami Herald investigation revealed that the DeSantis administration steered $10 million from a legal Medicaid settlement to a charity led by Florida First Lady Casey DeSantis. That charity then gave $5 million each to two organizations backing a political committee that opposed Amendment 3, the failed 2024 initiative to legalize adult-use cannabis in Florida.



The money flowed from the Hope Florida Foundation to Secure Florida's Future and Save Our Society from Drugs, which then routed millions to Keep Florida Clean, a DeSantis-aligned committee. Republican lawmakers are now demanding records and investigating whether public funds were improperly used to fight cannabis legalization.



<a class="" href="https://www.miamiherald.com/news/politics-government/article304020886.html">Full investigation by the Miami Herald</a>



<h3 class="wp-block-heading">State Moves And Brand Power Plays</h3>



Carmelo Anthony Launches STAYME7O In New York



Carmelo Anthony has entered the New York cannabis market with STAYME7O, a premium cannabis brand launched in partnership with Grand National, the creative agency he co-founded with Jesce Horton and Brandon Drew Jordan Pierce. The product line features curated flower cultivated by Oregon-based LOWD, with an emphasis on sustainability and unique genetics.



"This isn't just about cannabis—it's about empowering our communities," Anthony said. A portion of proceeds will support NuProject and the Last Prisoner Project, continuing the brand's focus on economic equity and justice reform.



<a class="" href="https://www.benzinga.com/general/sports/25/04/44801792/carmelo-anthony-enters-new-york-cannabis-market-all-about-his-product-line-and-creative-agency">Full story on Benzinga</a>



Curaleaf Turns Dispensary Into Hemp Shop



Curaleaf (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) has converted one of its medical dispensaries in West Palm Beach into a hemp-focused retail store called The Hemp Company. The location will offer Farm Bill-compliant THC products from Curaleaf brands and partners like 1906 and Cann.



The move comes as Curaleaf distances itself from Florida's stalled adult-use push and signals short-term interest in the rapidly growing hemp-derived THC segment.



Trulieve Invests $19.6M To Revive Legalization Push



Trulieve (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) contributed $19.6 million to Smart &amp; Safe Florida to support another attempt at adult-use legalization in 2026. That's in addition to the $145 million the company spent on the failed 2024 initiative.



So far, only 150,804 signatures have been verified out of the 880,062 needed to qualify for the next ballot, raising questions about whether other operators will step in to help fund the campaign.



Herbwell Cannabis Targets Manhattan's Elite



Herbwell, a national cannabis chain, is opening a luxury dispensary at 519 Madison Avenue—possibly the only one of its kind on the high-end Manhattan corridor. The shop promises a curated experience for both seasoned users and curious first-timers.



"We've built a gorgeous dispensary that fits in on Madison Avenue," said CEO Arish Halani. "One day we'll be doing collabs with the biggest brands in the world."



The brand is also planning to open a cannabis club in the building's upper floors, including a rooftop lounge overlooking Midtown, pending future regulations.



New Jersey's First E-Bike Weed Delivery



Hoboken dispensary Blue Violets has launched New Jersey's first cannabis delivery service by e-bike, in partnership with delivery tech company Priscotty. The program is live in Hoboken and parts of Jersey City and Weehawken.



"We want to reach our customers when they can't make their way to the store—but in a way that makes sense," said Lauren Thompson, co-owner of Blue Violets.



<h3 class="wp-block-heading">Culture And Commentary</h3>



Mike Tyson Becomes CEO Of Carma HoldCo



Boxing legend Mike Tyson has taken the reins as CEO of Carma HoldCo, the company behind TYSON 2.0, Ric Flair Drip, Evol by Future and Wooooo! Energy. The move marks Tyson's shift from brand ambassador to active executive, steering a portfolio built on cultural storytelling and celebrity power.



"This isn't just a title—it's a responsibility I take seriously," Tyson said. Under his leadership, Carma plans to double down on authenticity, community engagement and global expansion.



<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44871633/mike-tyson-cannabis-ceo-the-champ-now-runs-carma-holdco">Read the full story on Benzinga</a>



Weedmaps Drops 420 1's Sneaker Collab With CEEZE



In one of the most buzzworthy 4/20 drops of the year, Weedmaps and custom sneaker studio CEEZE released the limited-edition "420 1's." Each of the 420 pairs is individually numbered, housed in an acrylic box with LED lighting and linked to a microsite via QR code.



The Friends &amp; Family version even includes GPS coordinates pointing to the historic San Francisco Cannabis Buyers Club. A sweepstakes is running through April 20, offering 20 pairs and one VIP trip to Spannabis.



<a class="" href="https://weedmaps.com/wm-sneakers-420-1s">Details and entry here</a>



Swatch's 4/20 Watch Gets a Second Life



Swatch's "Up In Smoke" watch from 2024 has found new life this April. With minty green hues, smoke-dial graphics and a laid-back BIOCERAMIC case, the piece fits right into the 4/20 aesthetic. Originally part of the BIG BOLD collection, the watch has quietly become a seasonal flex for cannabis aficionados.



<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44878425/swatchs-up-in-smoke-watch-is-the-low-key-flex-of-4-20-season">Read the full feature on Benzinga</a>



Dreka Gates, Tiffany Haddish And Chamath Sound Off



Cannabis was also front and center in this week's cultural commentary. Highlights include:



<ul>
<li>Dreka Gates, in an exclusive interview, said: "Cannabis would be a trillion-dollar industry for Black and Brown communities—if it hadn't been criminalized." <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/39798605/dreka-gates-cannabis-would-be-a-trillion-dollar-industry-for-black-and-brown-communities-if-it-h">Read more</a></li>



<li>Tiffany Haddish remarked that "If men had period pain, weed would already be legal." <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/39797136/tiffany-haddish-if-men-had-period-pain-weed-would-already-be-legal">Full story here</a></li>



<li>Chamath Palihapitiya criticized the industry, saying legalization "turned our kids into zombies." <a class="" href="https://www.benzinga.com/general/health-care/25/04/44831042/chamath-palihapitiya-calls-for-mandate-on-insidious-marijuana-labelling-and-toxicity-says-its-turning-kids-into-zombies">His take here</a></li>
</ul>



<h3 class="wp-block-heading">Science And Health</h3>



Landmark Study Confirms Cannabis Benefits for Cancer Patients



In what may be the most comprehensive review of its kind, Cancer Playbook and the Whole Health Oncology Institute published a meta-analysis of over 10,000 peer-reviewed studies on medical cannabis and cancer. The result: a 3-to-1 scientific consensus in favor of cannabis for treating cancer-related symptoms, including inflammation, metastasis, appetite loss and pain.



"We expected controversy. What we found was overwhelming scientific consensus," said Ryan Castle, WHOI's head of research.



The study also incorporated patient-reported outcomes to highlight real-world effectiveness—marking a shift toward more holistic, experience-driven research models. Findings from this report were submitted to the DEA as part of the case for rescheduling cannabis.



<a class="" href="https://www.benzinga.com/general/health-care/25/04/44835610/game-changing-study-confirms-medical-cannabis-helps-cancer-patients-we-found-overwhelming-scientific-consensus">Link to the full Benzinga article</a>



Israel Slaps 165% Tariffs on Canadian Cannabis



In a dramatic turn, Israel's Ministry of Economy announced it will impose tariffs of up to 165% on Canadian cannabis imports for the next four years. The decision—pending approval by the Knesset Finance Committee—carves out exceptions for select producers like Decibel (12%), Village Farms (28%), Organigram (53%) and Tilray (70%).



The move signals a potential realignment of the global cannabis trade, with implications for both exporters and Israeli medical patients.



<a class="" href="https://stratcann.com">More via StratCann</a>



<h3 class="wp-block-heading">Recommended Reads</h3>



<ul>
<li><a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/14/he-sold-his-cannabis-vape-brand-for-nine-figures-now-hes-coming-for-your-cocktail/">He Sold His Cannabis Vape Brand for Nine Figures—Now He's Coming for Your Cocktail</a></li>



<li><a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44818968/how-one-european-company-is-flooding-america-with-cannabis-seeds">How One European Company Is Flooding America With Cannabis Seeds</a></li>
</ul>



That&#8217;s it for this week. See you next Friday!

Cannabis

Earnings

Politics

General

AVCNF

CURLF

SHFS

TCNNF

TLRY

TSX:AVCN

This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More

Each week, Benzinga&#8217;s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the <a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.



Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.



Read Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/25/04/44597684/exclusive-marchs-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-nvidia-apple-applovin-stock-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?</a>



Here's a look at the Benzinga Stock Whisper Index for the week ending April 17:



Equinix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>): The data center company saw strong interest from readers during the week. Citigroup recently <a href="https://www.benzinga.com/quote/EQIX/analyst-ratings">maintained a Buy </a>rating on the stock and lowered the price target from $1,020 to $970. Mizuho also lowered the price target from $1,094 to $1,053 recently while maintaining an Outperform rating. All eyes are likely centered on the company's upcoming first-quarter earnings report on April 30. Analysts expect the company to report revenue of $2.22 billion, up from $2.13 billion in last year's first quarter. Analysts expect the company to report quarterly earnings per share of $9.09, up from $8.86 in last year's first quarter. The company has had recent mixed results beating earnings per share in three of the last four quarters, while missing revenue estimates in four straight quarters. The stock was up around 5% over the last five trading sessions, as shown on the<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"> Benzinga Pro chart</a> below.



<figure class="wp-block-image size-full"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"><img loading="lazy" decoding="async" width="995" height="505" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17174940/Screenshot-379.png" alt="" class="wp-image-877779" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17174940/Screenshot-379.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17174940/Screenshot-379-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17174940/Screenshot-379-768x390.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>



Prologics Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>): The industrial and logistics REIT saw strong interest from readers during the week and rejoins the <a href="https://www.benzinga.com/markets/commodities/25/04/44651693/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Stock Whisper Index.</a> On April 16, the company <a href="https://www.benzinga.com/news/earnings/25/04/44837972/prologis-beats-q1-ffo-estimate-same-store-noi-up-6-2-y-y-more">reported earnings per share </a>of $1.42 that beat a Street consensus estimate of $1.38, while revenue of $2.00 billion missed a Street consensus estimate of $2.04 billion. The company has had mixed recent results, beating earnings per share in fourth straight quarters, while missing revenue estimates from analysts in six straight quarters. Several analysts <a href="https://www.benzinga.com/quote/PLD/analyst-ratings">lowered their price targets </a>on the stock recently. While the quarterly results showed growth, management commentary said that customers were being more cautious given "policy uncertainty." The company reiterated full-year guidance, but the commentary could be something to watch going forward.



<figure class="wp-block-image size-full"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"><img loading="lazy" decoding="async" width="991" height="499" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17174955/Screenshot-380.png" alt="" class="wp-image-877780" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17174955/Screenshot-380.png 991w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17174955/Screenshot-380-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17174955/Screenshot-380-768x387.png 768w" sizes="(max-width: 991px) 100vw, 991px" /></a></figure>



Alamos Gold Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGI#NYSE">AGI</a>): Gold stocks continue to be hot with Benzinga readers with Alamos taking its turn on the Stock Whisper Index with gold at <a href="https://www.benzinga.com/news/treasuries/25/04/44857989/gold-nears-3400-mark-experts-point-to-likely-correction-amid-bull-market-rates-will-drop-like-rock">all-time highs</a>. The stock recently got several <a href="https://www.benzinga.com/quote/AGI/analyst-ratings">price target increases</a> from analysts including Scotiabank and RBC Capital. Investors are preparing for the company to report first-quarter financial results on April 30. Analysts expect the company to report revenue of $357.2 million and earnings per share of 23 cents. The company has beaten revenue estimates from analysts in four straight quarters and seven of the last 10 quarters overall. On the earnings side, the company has beaten analyst estimates for EPS in seven of the last 10 quarters overall. Shares are up 98% over the last year and could have more upside from a strong earnings report and positive commentary on how the strong prices of gold are helping the company's future financials.



<figure class="wp-block-image size-full"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"><img loading="lazy" decoding="async" width="1001" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175012/Screenshot-381.png" alt="" class="wp-image-877781" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175012/Screenshot-381.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175012/Screenshot-381-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175012/Screenshot-381-768x384.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></a></figure>



Boston Scientific Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>): The medical devices company saw strong interest from readers during the week, which comes ahead of fourth-quarter financial results. The company also received <a href="https://www.benzinga.com/quote/BSX/analyst-ratings">an analyst upgrade</a> from Hold to Buy from Needham with a new price target of $113. Boston Scientific is set to report first-quarter financial results on April 23. Analysts expect the company to report revenue of $4.57 billion, up from $3.86 billion in last year's first quarter. The company has beaten analyst revenue estimates in more than 10 straight quarters. Analysts expect the company to report earnings per share of 67 cents, up from 56 cents per share in last year's first quarter. The company has beaten analyst estimates for earnings per share in eight straight quarters. There are some concerns about<a href="https://www.benzinga.com/general/biotech/25/04/44652075/us-tariffs-spare-drugmakers-but-threaten-diabetes-device-industry"> how tariffs could impact </a>medical devices, but Boston Scientific has remained a strong performer in the sector. The company said 2024 was one of the best years <a href="https://www.benzinga.com/general/health-care/25/02/43494194/boston-scientific-clocks-22-jump-in-q4-sales-on-strong-heart-devices-profit-and-guidance-exceeds-expectations">in its history</a>. Investors will be looking for a strong first quarter and positive commentary to kick things off in 2025.



<figure class="wp-block-image size-full"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"><img loading="lazy" decoding="async" width="1001" height="497" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175026/Screenshot-382.png" alt="" class="wp-image-877784" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175026/Screenshot-382.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175026/Screenshot-382-300x149.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175026/Screenshot-382-768x381.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></a></figure>



American Express Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>): The credit card company <a href="https://www.benzinga.com/news/earnings/25/04/44862333/american-express-q1-card-spending-strong-ceo-maintains-annual-outlook-contingent-on-economic-climate">reported first-quarter</a> financial results on Thursday with earnings per share of $3.64 beating an analyst estimate of $3.47 and revenue of $16.97 billion beating an analyst estimate of $16.94 billion. The company has beaten analyst estimates for revenue in two straight quarters and for earnings per share in four of the last five quarters. In the earnings results, the company reported strong Card Member spending and higher net interest income. The company said it is seeing steady spending and credit trends despite the macroeconomic concerns. Bank of America recently <a href="https://www.benzinga.com/analyst-ratings/upgrades/25/04/44768565/american-express-receives-upgrade-what-makes-this-stock-so-appealing">upgraded the stock</a> from Neutral to Buy given it high-quality customer base that could keep credit losses in check. During uncertain times, credit card spending could increase and American Express remains a stock to watch with the stock up around 16% over the last year.



<figure class="wp-block-image size-full"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"><img loading="lazy" decoding="async" width="995" height="505" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175041/Screenshot-383.png" alt="" class="wp-image-877785" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175041/Screenshot-383.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175041/Screenshot-383-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17175041/Screenshot-383-768x390.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>



Stay tuned for next week&#8217;s report, and follow Benzinga Pro for all the latest headlines and <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>



Read the latest Stock Whisper Index reports here:



<ul>
<li><a href="https://www.benzinga.com/25/03/44333602/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">March 14</a></li>



<li><a href="https://www.benzinga.com/trading-ideas/25/03/44448522/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-58" target="_blank" rel="noreferrer noopener">March 21</a></li>



<li><a href="https://www.benzinga.com/trading-ideas/25/03/44546189/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-59" target="_blank" rel="noreferrer noopener">March 28</a></li>



<li><a href="https://www.benzinga.com/markets/commodities/25/04/44651693/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">April 4</a></li>
</ul>



Read Next:



<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43041374/exclusive-how-high-will-sp-500-go-under-donald-trump-in-2025-readers-are-optimistic-26-say-this" target="_blank" rel="noreferrer noopener">EXCLUSIVE: How High Will S&amp;P 500 Go Under Donald Trump In 2025? Readers Are Optimistic, 26% Say This…</a></li>
</ul>

Exclusives

Trading Ideas

EQIX

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

<h2 class="wp-block-heading">New On The Block</h2>



<ul>
<li>Willow Tree Credit Partners seeks to sell a minority stake and is soliciting potential buyers, according <a href="https://www.bloomberg.com/news/articles/2025-04-15/private-credit-firm-willow-tree-is-said-to-explore-stake-sale?sref=TBDibEcD">to</a> Bloomberg. The New York-based firm has about $5 billion in <a href="https://www.benzinga.com/topic/asset-management">assets under management</a>.</li>
</ul>



<ul>
<li>Bloomberg also <a href="https://www.bloomberg.com/news/articles/2025-04-16/partners-group-said-to-weigh-options-for-telepass-stake-in-italy?sref=TBDibEcD">reports</a> that Zurich-based Partners Group is divesting a 49% stake in Italian toll road business Telepass. It first purchased the stake in 2021. Italy's Benetton family maintains control with a 51% stake.</li>
</ul>



<h2 class="wp-block-heading">Updates From The Block</h2>



<ul>
<li>GeneDx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSG#NASDAQ">WSG</a>) agreed to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation, for $33 million in cash . Upon achieving certain milestones, the total price tag <a href="https://www.benzinga.com/25/04/44843916/genedx-eyes-global-genomic-leadership-with-fabric-genomics-buyout-for-up-to-51-million">could potentially reach $51 million</a>.</li>
</ul>



<ul>
<li>Axios broke the news that a New Zealand-based metaverse company called Futureverse <a href="https://www.axios.com/2025/04/16/candy-digital-futureverse-mlb-nft">acquired</a> NFT startup Candy Digital. Major League Baseball, Netflix and DC Comics are among Candy Digital&#8217;s partners. That wasn&#8217;t the only metaverse deal this past week.</li>
</ul>



<ul>
<li>Infinite Reality, which boasts a $15-billion valuation, agreed to buy agentic AI company Touchcast for $500 million. Last month, Infinitie Reality acquired digital music innovator Napster <a href="https://www.benzinga.com/news/25/03/44546940/deal-dispatch-bezos-backed-crop-company-wilts-tech-startup-nabs-napster-for-207-million">for $207 million</a>.</li>
</ul>



<ul>
<li>Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) announced that it purchased a taxi app from BMW Group and Mercedes-Benz Mobility for €175 million <a href="https://www.benzinga.com/25/04/44841871/lyft-expands-to-europe-with-e175m-freenow-acquisition-targets-bookings-by-e1b-annually">($197 million) in cash</a>.</li>
</ul>



<h2 class="wp-block-heading">Off The Block</h2>



<ul>
<li>Onsemi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) terminated its efforts to acquire Allegro MicroSystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>). In early March, Allegro received a proposal from Onsemi, or ON Semiconductor Corporation, for $35.10 per share, with an implied <a href="https://www.benzinga.com/pressreleases/25/03/b44157898/onsemi-proposes-to-acquire-allegro-microsystems-for-35-10-per-share-in-cash" target="_blank" rel="noreferrer noopener">enterprise value of $6.9 billion</a>.</li>
</ul>



<ul>
<li>Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) closed its $4.1-billion acquisition of payroll and HR software firm Paycor HCM. The deal was first <a href="https://www.benzinga.com/25/01/42855388/paychex-buys-paycor-41-billion-deal-to-strengthen-ai-driven-hr-solutions">announced in January</a>.</li>
</ul>



<ul>
<li>TPG completed its $2.2-billion take-private buyout of Altus Power, the largest owner of commercial-scale solar in the U.S. Approximately 40% of the company&#8217;s stock is already committed to the deal. Altus Power expects the transaction to officially close <a href="https://www.benzinga.com/25/02/43537313/why-altus-power-stock-is-gaining-today">within the second quarter</a>.</li>
</ul>



<h2 class="wp-block-heading">Bankruptcy On The Block</h2>



<ul>
<li>Consolidated Burger Holdings, a Burger King franchisee operating 57 locations across Florida and Georgia, has filed for Chapter 11 bankruptcy. The company, based in Destin, Florida, cited financial struggles worsened by the COVID-19 pandemic, including reduced foot traffic and declining revenue, while costs like rent and debt service remained high. Its restaurants include sites in cities like Valdosta, Tallahassee, West Palm Beach, and Naples, with four located inside Walmart stores.</li>
</ul>



<ul>
<li>The House Committee on Energy and Commerce is investigating 23andMe&#8216;s Chapter 11 bankruptcy filing, raising concerns about the security of its sensitive genetic data. Lawmakers fear the company&#8217;s genetic database could be compromised as its assets are <a href="https://in.benzinga.com/25/03/44456578/why-dna-test-provider-23andmes-stock-is-plunging-today">now up for sale</a>. In a letter to interim CEO Joe Selsavage, three Republican congressmen requested answers about the company&#8217;s data and privacy practices by May 1. The inquiry follows similar concerns from the FTC and the House Oversight Committee. Once valued at $6 billion, 23andMe has struggled to maintain revenue and expand into research and therapeutics.</li>
</ul>



<a href="https://www.benzinga.com/news/asset-sales/25/04/44771660/deal-dispatch-harley-davidson-prada-versace-fashionable-price">Check out last week&#8217;s edition of the Deal Dispatch</a>.



Now Read:



<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/04/44876137/grant-cardone-explains-the-art-of-negotiating-it-takes-4-things-to-make-a-deal">Grant Cardone Explains The Art Of Negotiating: &#8216;It Takes 4 Things To Make A Deal&#8217;</a></li>
</ul>

Asset Sales

ALGM

GRPN

LYFT

PAYX

Deal Dispatch: Metaverse Mergers, 23andMe Under Investigation, Burger King Franchise Goes Bankrupt

<ul>
<li>On Monday, Meta and the FTC began a faceoff in court over monopoly claims</li>



<li>If the FTC wins, Meta will be forced to sell off apps like Instagram and WhatsApp</li>



<li>Meta CEO Mark Zuckerberg's relationship with President Donald Trump has been called into question, as many worry that it could potentially sway the outcome of the trial</li>
</ul>



The US government began a closely watched aantitrust case against Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) on Monday. The Federal Trade Commission's <a href="https://www.ftc.gov/legal-library/browse/cases-proceedings/191-0134-facebook-inc-ftc-v-ftc-v-meta-platforms-inc">suit alleges</a> that the company has illegally built a "social networking monopoly" through years of "anticompetitive conduct." Defending his company's actions, Meta CEO Mark Zuckerberg took the stand on the first day of proceedings, answering questions about the company's intentions in purchasing apps like Instagram and WhatsApp, and his oft-repeated philosophy "it's better to buy than compete," according to the <a href="https://apnews.com/article/meta-ftc-antitrust-instagram-whatsapp-facebook-f602a09e86c9eb4538949572f72e8380">Associated Press</a>.&nbsp;



If the government wins the case, Meta will be forced to sell off Instagram and WhatsApp, and other tech giants, like Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>, GOOG)) and Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), would be put on notice.



Don't Miss:



<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>



<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>



Historically, the FTC has operated with a large degree of independence, meaning its investigators have been shielded from political pressure. But over the course of his second term, President Donald Trump seems to be bucking those norms. This could have a significant impact on the outcome of the case.



In January, <a href="https://www.nytimes.com/2025/01/30/technology/mark-zuckerberg-meta-trump.html">The New York Times</a> reported that Zuckerberg told employees, "We now have an opportunity to have a productive partnership with the United States government," and "we're going to take that." His comments came after months of private dinners with Trump and those his camp, trips to Mar-a-Lago, and policy changes on his platforms that benefited Trump. The Times reported earlier this month that Zuckerberg visited the White House to urge Trump to intervene in the case.



At the time, a Meta spokesman Andy Stone, told the Times that the company "regularly meets with policymakers to discuss issues impacting competitiveness, national security, and economic growth," essentially implying that the visit wasn't out of the norm. But still, the meeting has raised concerns that Zuckerberg and Meta have been unfairly attempting to sway the outcome in their favor.



Trending: Maker of a life-changing asthma device with 12,000+ patients waiting, FDA clearance, and a 67% drop in attacks — now <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">taking final investors at just $1.52 per share.</a>



But the question remains, will it work? Maybe, maybe not.



The biggest hurdle will be the U.S. district judge assigned to the case, Judge James Boasberg. Described by Trump as a "Radical Left Lunatic," Boasberg has a nonpartisan record and a sterling reputation in legal circles. However, he has rejected Meta's bids to dismiss the suit once, and seems to be unswayed by Trump so far, ruling against the president's use of the Alien Enemies Act to deport alleged gang members, although he was largely overruled by the Supreme Court.



But Meta isn't giving up. Ahead of the trial, a company spokesman told <a href="https://www.cnn.com/2025/04/14/media/meta-ftc-trial/index.html">CNN</a>, "Regulators should be supporting American innovation, rather than seeking to break up a great American company and further advantaging China on critical issues like AI." And Meta reportedly plans to argue at trial that it remaining so large and expansive is critical, as it provides an American answer and competitor to foreign-owned platforms like TikTok and domestic competitors like YouTube and X, per CNN.&nbsp;



Read Next:



<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>



<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
</ul>



Image: Shutterstock

AMZN

GOOGL

Meta Faces An Antitrust Lawsuit, FTC Says Company Holds A 'Social Network Monopoly'

In a surprising turn of events, the&nbsp;acting commissioner of the Internal&nbsp;Revenue Service (IRS) has been replaced, following a dispute with billionaire&nbsp;Elon Musk. The move comes amidst increasing concerns over Musk&#8217;s influence within the Trump administration.



What Happened: The interim head of the IRS, Gary Shapley, was replaced after a disagreement with Musk. The report suggests that Musk, through his Department of Government Efficiency, had pushed for Shapley&#8217;s appointment, bypassing Treasury Secretary Scott Bessent.



As per the report <a href="https://www.nytimes.com/2025/04/18/us/politics/irs-scott-bessent-elon-musk.html">by </a>New York Times, Bessent, who was reportedly unaware of Musk&#8217;s involvement, expressed his dissatisfaction to President Trump, who then approved the reversal of Shapley&#8217;s appointment.



The Deputy Secretary of the Treasury, Michael Faulkender, is expected to step in as the acting head of the IRS. He will hold the position until the Senate approves the President&#8217;s nominee for the permanent role, former congressman Billy Long.



Also Read: <a href="https://www.benzinga.com/news/25/04/44778605/elon-musk-digging-my-own-grave-by-tying-himself-to-doge">Elon Musk: &#8216;Digging My Own Grave&#8217; by Tying Himself to DOGE</a>



This leadership change at the IRS is the latest in a series of temporary appointments under the Trump administration. 



The previous interim head, Melanie Krause, resigned after the Treasury Department decided to use IRS data to assist Immigration and Customs Enforcement in deporting undocumented immigrants.



The IRS has declined to comment on the situation. However, this incident underscores the growing concern over Musk&#8217;s&nbsp;influence in the Trump administration, adding to the existing turmoil within the IRS.



Why It Matters: This incident is indicative of the ongoing power struggles within the Trump administration, particularly regarding the influence of private sector figures like Musk. 



The frequent changes in leadership at the IRS, a crucial government agency, could potentially impact its effectiveness and stability. 



Moreover, the use of IRS data for immigration enforcement has raised ethical and legal questions, adding another layer of complexity to the situation.



Read Next



<a href="https://www.benzinga.com/news/25/02/43768756/privacy-concerns-emerge-as-elon-musks-doge-team-seeks-access-to-taxpayer-data" target="_blank" rel="noreferrer noopener">Privacy Concerns Emerge As Elon Musk's DOGE Team Seeks Access to Taxpayer Data</a>

IRS Leadership Shakeup Following Clash With Elon Musk

A&nbsp;Boeing Co.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) aircraft, originally intended for delivery to China, was redirected back&nbsp;to the U.S. on&nbsp;Friday. This incident underscores the intensifying tariff dispute between Beijing and Washington.



What Happened: The jet, one of several awaiting final preparations at Boeing&#8217;s Zhoushan facility, was flown back to the U.S. without delivery. This move follows the imposition of tariffs by U.S. President Donald Trump on April 2, which has disrupted the longstanding duty-free status of the aerospace industry.



According to Reuters, the aircraft, initially slated for Xiamen Airlines, was seen returning to Seattle via Guam.



The decision comes amid reports of a potential Chinese ban on Boeing imports, although no official statement has been made by Beijing.



See Also: <a href="https://www.benzinga.com/25/04/44888445/ford-reportedly-halts-vehicle-shipments-to-china-amid-rising-tariffs">Ford Reportedly Halts Vehicle Shipments To China Amid Rising Tariffs</a>



Industry insiders have indicated that Boeing and its suppliers are preparing for a&nbsp;halt in deliveries to China, according to the report.



Despite discussions about storing undelivered jets in bonded facilities to avoid tariffs, the aircraft was repatriated.



The Air Current first reported the withdrawal of&nbsp;some undelivered jets from Zhoushan,&nbsp;noting that a Chinese airline had also backed out of leasing a Boeing plane.



Why It Matters: The decision to redirect the Boeing jet back to the U.S. is a direct consequence of the escalating trade tensions between the two economic giants.



The Trump administration recently announced tariffs <a href="https://www.benzinga.com/markets/25/04/44831287/trump-administration-imposes-up-to-245-tariff-on-chinese-imports-amid-intensifying-trade-battle">of up to 245%</a> on Chinese imports, a move that has intensified the trade battle between the nations. This has led to retaliatory measures from China, including a potential ban on Boeing aircraft, which could significantly impact the aerospace industry.



China&#8217;s decision to halt Boeing purchases could also have repercussions for its own aircraft manufacturer,&nbsp;<a href="https://www.benzinga.com/news/global/25/04/44883727/chinas-boeing-ban-could-backfire-on-its-own-aircraft-manufacturer-comac">Comac</a>, which relies heavily on U.S. technology. The move could hinder Comac&#8217;s efforts to become globally competitive, as highlighted in a report by the Wall Street Journal.



Analysts, including those <a href="https://www.benzinga.com/markets/25/04/44837703/chinas-ban-on-boeing-could-be-short-lived-but-trump-administration-cant-ignore-trade-fallout-warns-analyst">from</a>&nbsp;Bank of America, have warned that while the ban on Boeing could be temporary, the Trump administration cannot overlook the broader trade implications.



Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">&nbsp;following this link.</a>



Read Next:



<ul>
<li><a href="https://benzinga.com/markets/equities/25/04/44655841/if-youre-going-to-do-dumb-things-because-your-stock-goes-down-warren-buffetts-old-warning-gains-steam-as-us-stocks-wipe-out-5-trillion-after-trump-tariffs" target="_blank" rel="noreferrer noopener">&#8216;If You&#8217;re Going To Do Dumb Things Because Your Stock Goes Down…:&#8217; Warren Buffett&#8217;s Old Warning Gains Steam As US Stocks Wipe Out $5 Trillion After Trump Tariffs</a></li>
</ul>



Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.



Photo courtesy: Shutterstock

Boeing Jet Returns To US Amid Escalating Tariff Tensions With China

The U.S. Supreme Court temporarily paused the <a href="https://www.benzinga.com/politics/25/04/44680699/alien-enemies-act-survives-court-challenge-trump-gains-green-light-for-swift-deportations">deportation of immigrants</a> under the Alien Enemies Act, drawing criticism from conservative justices Samuel Alito and Clarence Thomas.



What Happened: Early on Saturday morning, the Supreme Court issued a brief order halting deportations under the 18th-century law, which the Donald Trump administration had invoked to remove a group of Venezuelan immigrants in Texas, <a href="https://edition.cnn.com/2025/04/18/politics/boasberg-deportation-flights-alien-enemies-act/index.html">reported</a> CNN.



The immigrants, fearing imminent deportation, filed an emergency appeal, claiming they had not been given proper notice or a chance to challenge their removal.



See Also:&nbsp;<a href="http://benzinga.com/25/04/44888232/trumps-top-economic-adviser-kevin-hassett-says-white-house-is-exploring-options-to-fire-fed-chair-jerome-powell-the-president-and-his-team-will-continue-to-study" target="_blank" rel="noreferrer noopener">Trump's Top Economic Adviser Kevin Hassett Says White House Is Exploring Options To Fire Fed Chair Jerome Powell: ‘The President And His Team Will Continue To Study'</a>



The court did not explain its decision but directed the Trump administration to respond after a federal appeals court in Louisiana reviews the case. The court's order stated that no members of the &#8220;putative class of detainees&#8221; could be removed until further instructions from the court.



Justice Alito and Justice Thomas dissented from the order. Alito questioned the need for the court's involvement, while Thomas expressed concern over the potential implications of halting the removals.



Why It&#8217;s Important: The case stems from a challenge to the Trump administration&#8217;s use <a href="https://www.benzinga.com/25/03/44428767/trump-administration-failed-to-respond-to-court-order-on-deportation-flights-explain-non-compliance-by-tuesday-says-judge">of the Alien Enemies Act</a>, which allows the government to bypass normal immigration procedures and remove individuals from the country.



In a prior ruling, the Supreme Court had allowed the administration to proceed with deportations under the Act but required the government to provide notice and allow detainees to challenge their removal in court.



Read Next:



<ul>
<li><a href="https://benzinga.com/25/03/44554189/openai-and-microsoft-back-mcp-standard-in-major-shift-toward-interoperable-ai-agents-that-can-think-click-and-navigate-the-web-but-google-ceo-sundar-pichai-appears-to-be-mulling-over-it-in-shakespearean-fashion-to-mcp-or-not-to-mcp" target="_blank" rel="noreferrer noopener">OpenAI And Microsoft Back MCP Standard For Web-Surfing AI Agents; Google&#8217;s Sundar Pichai Asks A Shakespearean Question</a></li>
</ul>



Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.



Photo courtesy: Shutterstock

Legal

Media

Supreme Court Temporarily Halts Immigrant Deportations Under Alien Enemies Act By Trump White House: Conservative Judges Voice Dissent

On Friday, White House National Economic Council chair Kevin Hassett said the Donald Trump administration is exploring <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44861571/donald-trump-blasts-too-late-and-wrong-fed-chair-powell-but-polymarket-traders-doubt-his-termination-will-come-fast-enough">ways to remove</a> Federal Reserve Chairman Jerome Powell.



What Happened: Hassett told reporters at the White House that the &#8220;President and his team will continue to study,&#8221; whether it&#8217;s possible to fire Powell, <a href="https://thehill.com/business/5256173-trump-exploring-firing-fed-chair/">reported</a> The Hill.



The legal framework surrounding Powell's position complicates any potential firing. According to a 90-year-old Supreme Court precedent, a Federal Reserve chair can only be removed for misconduct or severe neglect of office.



Powell has repeatedly stated that he cannot be legally removed from office and has insisted he <a href="https://www.benzinga.com/startups/25/02/43493701/fed-chair-jerome-powell-faces-trumps-pressure-the-president-cant-fire-me-as-interest-rates-hold-steady-at-4-25-4-5">would serve his full term</a>.



See Also: <a href="https://www.benzinga.com/general/space/25/04/44882314/tesla-ceo-elon-musk-indian-pm-modi-discuss-deeper-tech-ties-amid-model-y-test-run-in-mumbai">Tesla CEO Elon Musk, Indian PM Modi Discuss Deeper Tech Ties Amid Model Y Test Run In Mumbai</a>



Why It&#8217;s Important: Hassett's comments followed a <a href="https://www.benzinga.com/government/regulations/25/04/44862662/trump-pressures-fed-as-ecb-delivers-7th-straight-rate-cut">series of public attacks</a> from President Trump, who has been increasingly critical of Powell, particularly over the Fed's refusal to cut interest rates.



Trump's anger toward Powell intensified this week, culminating in a Thursday morning post on social media where the president expressed his frustration, saying he couldn&#8217;t wait for Powell&#8217;s &#8220;termination.&#8221;



This followed <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44848474/fed-chair-powell-says-tariffs-lead-to-temporary-rise-in-inflation">Powell's warnings that Trump's trade</a> tariffs could fuel inflation and cause a slowdown in economic growth, a scenario Trump has said would prevent the Fed from making the necessary rate cuts.



The potential dismissal of Powell has raised concerns about the stability of U.S. financial markets. <a href="https://www.benzinga.com/markets/25/04/44882256/trumps-threat-to-fire-powell-could-shake-us-financial-markets">Investment strategists</a> have warned that such a move could undermine the independence of the Federal Reserve and cause significant market turbulence.



Sen. Elizabeth Warren (D-Mass.) has also cautioned that firing Powell could lead to a <a href="https://www.benzinga.com/markets/25/04/44883756/warren-foresees-market-turmoil-if-trump-dismisses-feds-powell-if-powell-can-be-fired-by-trump-it-will-crash-markets">stock market collapse</a>.



Read Next:



<ul>
<li><a href="https://benzinga.com/25/03/44554189/openai-and-microsoft-back-mcp-standard-in-major-shift-toward-interoperable-ai-agents-that-can-think-click-and-navigate-the-web-but-google-ceo-sundar-pichai-appears-to-be-mulling-over-it-in-shakespearean-fashion-to-mcp-or-not-to-mcp" target="_blank" rel="noreferrer noopener">OpenAI And Microsoft Back MCP Standard For Web-Surfing AI Agents; Google&#8217;s Sundar Pichai Asks A Shakespearean Question</a></li>
</ul>



Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.



Photo courtesy: Domenico Fornas / Shutterstock.com

Federal Reserve

Trump's Top Economic Adviser Kevin Hassett Says White House Is Exploring Options To Fire Fed Chair Jerome Powell: 'The President And His Team Will Continue To Study'

Ask 10 people what it takes to be <a href="https://www.benzinga.com/25/03/44131089/kevin-oleary-says-making-1-million-is-almost-impossible-but-getting-to-5-million-is-surprisingly-easier">financially set for life</a>, and most will throw out numbers with lots of commas: $5 million, $10 million, maybe more if they're feeling pessimistic about inflation and avocado prices. But Kevin O'Leary, entrepreneur and "Shark Tank" mainstay, says the real magic number isn't in the millions. It's $500,000.



In a <a href="https://youtube.com/shorts/TcpVd9VmE7M?si=oahf9HaAfL1BgPEU">2023 YouTube short</a>, O'Leary tackled the question head-on: How much do you need to live a comfortable or wealthy life? His answer? That depends on your lifestyle. But for many people, he says, half a million bucks in the bank can do the trick.



Don't Miss:



<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>



<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>



"It's all about lifestyle," he says in the clip. "You can live off half a million bucks in the bank and do nothing else to make money."



Sounds too good to be true? It depends on what you do with that money and more importantly, what you don't do with it.



O'Leary explains if you're investing wisely, you could reasonably earn around 5% annually in fixed income with "very little risk." That's $25,000 a year without touching your principal — enough to cover modest living expenses, especially if you own your home and live in a low-cost area. Want to push that income a little higher? According to O'Leary, you could aim for 8.5% to 9% returns by mixing in equities, if you're willing to "ride the volatility."



Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>



That added risk comes with potential reward but also potential stress. The market doesn't always cooperate, and while equities historically trend upward, there's no guarantee they'll behave when you need them to. If the idea of watching your <a href="https://www.benzinga.com/personal-finance/25/03/44316684/warren-buffett-said-bad-news-is-an-investors-best-friend-and-if-youre-not-ready-for-stocks-to-drop-50-you-shouldnt-be-investing">portfolio dip during a downturn</a> sends your blood pressure soaring, you might want to stick with the slower but steadier option.



But O'Leary isn't just handing out ideas — he's got strong feelings about what not to do.



"Do not invest in your brother's restaurant or a bowling alley or a bar," he warns. "Or all that other crap. You'll lose your money on that."



Point taken.



See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.



Still, his $500,000 plan isn't for everyone. Even at a 6% return, that's $30,000 a year — not exactly luxury living, especially with rising medical costs, rent, and a grocery bill that seems to laugh at budgets.&nbsp;



Even with higher returns near 9%, you'd be working with about $45,000 a year — enough to get by, but probably not enough to quit your job unless your house is paid off, you have no debt, and you live a lean, frugal lifestyle. O'Leary did say it all comes down to <a href="https://www.benzinga.com/personal-finance/25/02/43539942/are-you-rich-heres-what-americans-think-you-need-to-be-considered-wealthy-2">your standard of living</a>, but for most people, living comfortably on that setup would require a serious commitment to keeping expenses low.



O'Leary's advice is simple, direct, and depending on your lifestyle…surprisingly doable. But his real point might be this: the path to financial freedom isn't always paved with millions. Sometimes, it's about knowing what you want, avoiding bad investments, and <a href="https://www.benzinga.com/personal-finance/25/02/43759618/charlie-munger-said-the-hardest-part-of-getting-rich-is-the-first-100000-but-from-there-it-snowballs-and-you-can-ease-off-the-gas">letting compound interest do the heavy lifting</a>.



Read Next:



<ul>
<li>With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.</li>



<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>



Image: Shutterstock

Personal Finance

Kevin O'Leary Says $500,000 Is The Magic Number To Live Comfortably — 'You Can Live Off Half A Million Bucks And Do Nothing Else To Make Money'

Wall Street wrapped up a shortened trading week ahead of the Easter holiday in the red, weighed down by fresh export restrictions on chips to China that sent tech <a href="https://www.benzinga.com/topic/chipmakers">and semiconductor stocks tumbling.</a>



On Tuesday, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) revealed it was notified by the Trump administration on April 9 that its H20 AI chip would now require an export license to be sold in China. The company warned that these tighter controls could slash its <a href="https://www.benzinga.com/government/regulations/25/04/44846329/nvidias-china-sales-face-setback-as-h20-chip-restrictions-catch-key-buyers-off-guard-reuters">earnings by $5.5 billion.</a>



Nvidia shares dropped 8.5% this week, erasing nearly half of the previous week&#8217;s gains. The broader semiconductor sector – as tracked by the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) – followed suit, sliding 3% and logging its seventh weekly decline <a href="https://www.benzinga.com/general/health-care/25/04/44860240/unitedhealth-slashes-2025-outlook-on-medicare-funding-reductions-stock-crashes">out of the past eight.</a>



First-quarter earnings season delivered a mixed bag. While banks and streaming giant Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) showed solid performance, UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shocked investors by slashing its full-year guidance far below Wall Street expectations.



UnitedHealth shares plummeted 22.4% on Thursday, marking their worst one-day drop since 1998.



In trade news, Canada announced a six-month suspension of countermeasure tariffs on select U.S. goods essential for domestic manufacturing and food packaging. This move is expected to ease cross-border supply chain pressures, particularly<a href="https://www.benzinga.com/25/04/44816653/canada-eases-retaliatory-tariffs-on-us-goods-as-trade-tensions-thaw-under-softer-trump-stance-stocks-react"> benefiting Michigan-based automakers.</a>



On the macro front, Federal Reserve Chair Jerome Powell flagged inflation and growth risks stemming from trade tariffs, reiterating the Fed&#8217;s cautious stance and signaling that rate cuts <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44848474/fed-chair-powell-says-tariffs-lead-to-temporary-rise-in-inflation">won&#8217;t come prematurely.</a>



This cautious tone triggered an angry response from President Donald Trump, who blasted Powell as "always too late" on rate cuts and hinted at prematurely removing him from office, despite Powell's term <a href="https://www.benzinga.com/government/regulations/25/04/44862662/trump-pressures-fed-as-ecb-delivers-7th-straight-rate-cut">running through May 2026.</a>



Meanwhile, the European Central Bank executed its sixth consecutive rate cut, further fueling Trump's public frustration with the Fed. During an Oval Office meeting with Italian Prime Minister Giorgia Meloni, Trump doubled down, declaring that Powell &#8220;will be out <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44875406/hell-be-out-if-i-ask-him-can-trumps-threat-to-oust-powell-shake-the-fed">if the President asks.&#8221;</a>



Gold continues to defy gravity, fueled by strong investor demand, heightened policy uncertainty, and persistent central bank buying.



Bullion prices – as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) – soared to $3,330 per ounce, marking a new all-time high and extending gains to 14 of the past 16 weeks.



Read now: 



<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44885051/netflix-beats-wall-street-forecasts-yet-goldman-sachs-sees-limited-upside-ahead">Netflix Beats Wall Street Forecasts, Yet Goldman Sachs Sees Limited Upside Ahead</a></li>
</ul>



Image: Shutterstock/Westlight

Broad U.S. Equity ETFs

SOXX

Trump Blasts Powell, Nvidia Tumbles On New Export Ban, Gold Defies Gravity: This Week In Markets

Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has gone from being an <a href="https://www.benzinga.com/topic/artificial-intelligence">AI crown jewel</a> to a geopolitical chess piece. And, it looks like Wall Street just got a front-row seat to a high-stakes poker game between Washington and Beijing.



After weeks of tension, the first real blow in the U.S.-China tech trade war has landed: the White House is blocking Nvidia's H20 chip sales to China. "This week were the first shots fired in the trade war in the tech world," said Wedbush analyst Dan Ives.



With 145% reciprocal tariffs in play, and tech still awaiting Section 232 hits &#8211; Nvidia is now "caught in the eye of this Category 5 storm," said Ives. While the financial damage may be manageable for now, the strategic signal is deafening. America's most prized chipmaker just got walled off from the world's second-largest economy. "Nvidia is one of the most important pieces in this chess game with China&#8230;and restricting its H20 chips is an important move that will clearly spark more actions from Beijing."



Read Also: <a href="https://www.benzinga.com/25/04/44882893/billionaire-peter-hargreaves-backed-fund-offloads-stake-in-meta-microsoft-amid-global-economic-woes">Billionaire Peter Hargreaves-Backed Fund Offloads Stake In Meta, Microsoft Amid Global Economic Woes</a>



Meanwhile, CEO Jensen Huang is reportedly in China &#8211; an eyebrow-raising detail amid rising tensions. As Ives puts it, "the Street waits for the next poker move."



While Nvidia's dominance in AI remains unchallenged, the short-term turbulence is real. The market is already "baking in a 7%-10% (or more) cut to 2025 numbers across the board," Ives says. The upcoming June quarter? A mulligan, with "minimal/no guidance expected during this earnings season."



Adding fuel to the fire: Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) and others are now seeing similar restrictions, a trend that's been brewing since the Biden administration but is now front and center in Trump's trade war redux. Ives doesn't mince words: "The Trump Administration knows there is one chip and company fueling the AI Revolution and it's Nvidia… and put a ‘Do Not Enter' sign in front of China."



Nvidia remains the ace in America's AI hand &#8211; but right now, it's being played in a global poker game, not an earnings report.



Read Next: 



<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44883683/xi-jinpings-minister-urges-nvidia-us-firms-to-invest-more-in-china-during-meeting-with-jensen-huang-despite-chip-export-curbs">Xi Jinping&#8217;s Minister Urges Nvidia, US Firms To Invest More In China During Meeting With Jensen Huang, Despite Chip Export Curbs</a></li>
</ul>



Image: Shutterstock/gguy

Analyst Color

Long Ideas

Analyst Ratings

Nvidia's 'Do Not Enter' Sign: Caught In A Category 5 Tariff Storm

Mark Cuban isn't interested in patching up the healthcare system with duct tape and buzzwords. He wants to rip it open, throw it under a spotlight, and ask what a lot of Americans are already thinking: Why is this entire industry allowed to operate in complete darkness?



In a February <a href="https://hospitalogy.com/articles/2025-04-04/i-just-wanna-fck-up-healthcare/">fireside chat</a> with Hospitalogy founder Blake Madden—later revisited in April—the billionaire behind Cost Plus Drugs didn't hold back. He took aim at insurance companies, hospitals, consultants, and just about anyone profiting off the confusion. And yes, he said it: "I don't think there's a reason that health insurance should exist."



Don't Miss:



<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>



<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>



Cuban's not looking to <a href="https://www.benzinga.com/25/02/43932776/mark-cuban-slams-fd-up-healthcare-system-blames-insurance-designed-deductibles-for-patient-bankruptcy">compete with insurers</a>. He just wants to make them irrelevant. "We're going to try to make it so that self-insured employers have no reason to work with insurance companies," he said. In his view, insurers approve plans that restrict access and bury costs behind layers of red tape. Worse, they don't even ask the most basic questions.



"Why is the health of our entire country based on providers who don't know their own f&#x2A;cking costs?" he asked.



Hospitals don't get a pass either. Cuban blasted their refusal to publish general ledgers or disclose what procedures and services actually cost. He called out the culture of secrecy, noting that executives are afraid of what transparency might reveal. "People don't want to do that because they're scared of what it would do for their business."



Trending: Maker of a life-changing asthma device with 12,000+ patients waiting, FDA clearance, and a 67% drop in attacks — now <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">taking final investors at just $1.52 per share.</a>



To Cuban, that's more than just bad management—it's a moral failure. "This isn't the Dallas Mavericks," he said. "This is the health and welfare of our entire country."



And while he proudly calls himself a capitalist, he draws a line when it comes to healthcare. "You don't have to just grab every nickel that you can get when there's this at stake."



If the <a href="https://www.benzinga.com/25/03/44530674/mark-cuban-vows-to-revamp-us-healthcare-by-empowering-independent-pharmacies-wants-no-pharmacy-deserts">industry refuses to act on its own</a>, Cuban believes it's time for regulators to step in. Not to micromanage. Not to take over. Just to require the basics.



"You've got to open the books," he said.



He's pushing for laws that would force hospitals and insurers to disclose actual costs, margins, and spending—something he says should be standard practice in any business that <a href="https://www.benzinga.com/startups/25/02/43662970/mark-cuban-says-u-s-healthcare-is-horrific-calls-for-free-medical-school-to-fix-doctor-shortages-and-soaring-costs">deals with life-and-death decisions</a>. If transparency threatens the business model, Cuban's argument is simple: maybe that business shouldn't exist in the first place.



Read Next:



<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>



<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
</ul>



Image: Shutterstock

Mark Cuban Says Health Insurance Shouldn't Exist — 'You Don't Have to Grab Every Nickel When It's the Health of the Entire Country at Stake'

The Symbol CLSL was not found. Here are some similar symbols and popular symbols to consider.

CLSL Page Not Found - Benzinga

Symbol Similar to: CLSL

Top Gaining Stocks

뉴스

파트너 / 기고자

벤징가 글로벌